Nicolas Musi, MD
Research expertise is in aging, insulin resistance and exercise physiology. Research program in metabolic/endocrine gerontology, is devoted to exploring the effects that aging has on numerous metabolic and cellular processes, and relevant to the patho-genesis of age-related diseases such as diabetes, obesity, and sarcopenia.
Clinical interests include pathogenesis, prevention and treatment of diabetes in the elderly, molecular mechanisms underlying sarcopenia of aging, and effects of exercise on glucose and lipid metabolism at the whole-body and cellular levels.
Vincent Mysliwiec, MD, FAASM
Vincent Mysliwiec, MD, FAASM, is a leading expert in sleep and sleep disorders in military personnel and veterans. Dr. Mysliwiec has over 15 years of experience conducting research in military populations and has authored over 70 scientific manuscripts. His research has led to insights into the clinical sleep disorders military personnel and veterans have, to include comorbid insomnia and obstructive sleep apnea and the proposed parasomnia, trauma associated sleep disorder. His current research includes the largest study to date, evaluating gender differences in sleep disorders in military men and women, further development of trauma associated sleep disorder and the first questionnaire to evaluate sleep disorders in military personnel.
Alicia Parker, MD
Assistant Professor of Cognitive and Behavioral Neurology
Co-Director of the Frontotemporal Dementia Clinic
Diversity Ambassador for the Biggs Institute
Within the field of memory disorders, there is a strong need for increased clinical resources, research studies and educational training. With this in mind, Dr. Parker has worked to bring clinical, research and educational opportunities to the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Disorders.
As the first physician to join the Biggs Institute, and the first Cognitive and Behavioral Neurologist to practice in Bexar County, Dr. Parker established the Memory Disorders Clinic and the multidisciplinary MIND clinic. She is the Co-Director of the FTD Clinic. Dr. Parker was peer elected as a 2021 Best S.A. Female Doctor by Scene in S.A. Magazine.
Dr. Parker has helped bring research opportunities to patients with dementia and their caregivers. She has been a Sub-Investigator on several clinical trials including the NIC MIND trial, the MarkVCID study and the T2 Protect AD trial. She is the Site Principal Investigator of the Trailblazer-Alz 2 Trial. She is the Principal Investigator of the Diastolic Dysfunction and the Development of Dementia study.
Regarding educational training, Dr. Parker gives didactic instruction in research and cognitive topics. She has helped develop clinical rotations for students, residents and fellowship programs, and is a member of the Neurology Residency Program Evaluation Committee.